Search clinical trials for: Multihance

Total 28 results

Bracco Diagnostics, Inc

Completed

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain (ENHANCE)

Brain Pathology

United States
Bracco Diagnostics, Inc

Completed

Multihance Versus Magnevist in Breast MRI (DETECT)

Breast Cancer

Italy
Bracco Diagnostics, Inc

Completed

A Pharmacokinetics Study of MultiHance in Pediatric Patients

Central Nervous System Pathology

Poland
Bracco Diagnostics, Inc

Completed

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

Peripheral Vascular Disease

Italy
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bracco Diagnostics, Inc

Completed

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. (TACE)

Hepatocellular Carcinoma

United States
Bracco Diagnostics, Inc

Completed

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

Steno-occlusive Disease

Italy
Bracco Diagnostics, Inc

Completed

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain (MERIT)

Brain Lesions

Canada
Bracco Diagnostics, Inc

Terminated

Safety and Efficacy of MultiHance in Pediatric Patients

Central Nervous System Diseases

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Central Nervous System Diseases | Central Nervous System Neoplasms

United States
Bracco Diagnostics, Inc

Completed

Retrospective Study of MRI in Pediatric Patients

Central Nervous System Neoplasms | Central Nervous System Disease
Technical University of Munich

Completed

Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI (Gadovit)

Subacute/Chronic Myocardial Infarction

Germany
Bracco Diagnostics, Inc

Completed

Crossover Comparison of MultiHance and Dotarem (BENEFIT)

Brain Disease

United States
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Bracco Diagnostics, Inc

Completed

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries (VALUE)

Carotid, Aortic, Renal or Peripheral Artery Disease

China
Bracco Diagnostics, Inc

Completed

Multihance at 3 Tesla (3T) in Brain Tumors

Brain Tumor

United States
University of Colorado, Denver
National Cancer Institute (NCI); Bracco Diagnostics, Inc

Recruiting

Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

Colorectal Cancer | Liver Metastases | Oligometastatic Disease

United States
University of Michigan

Completed

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Liver Tumor

United States
Cedars-Sinai Medical Center

Completed

Identification of Adverse Plaque Characteristics by Coronary MR Angiography

Coronary Artery Disease

United States
University of Wisconsin, Madison
National Cancer Institute (NCI); National Center for Advancing Translational...

Completed

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Breast Cancer | Ductal Carcinoma in Situ - Category

United States
Donna Roberts
National Institute of Standards and Technology

Recruiting

Gadolinium Retention in Human Bone Tissue in Pediatric Patients

Magnetic Resonance Imaging | Gadolinium Retention | Gadolinium | MultiHance | Dotarem

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

Lymphoma | Brain Neoplasm | Metastatic Malignant Neoplasm in the Brain | Recurrent Malignant Brain Neoplasm

United States
University of Utah

Completed

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients (RECAD-AF)

Coronary Artery Disease | Atrial Fibrillation

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Recruiting

Study of 18F-FFNP Breast PET/MRI

Breast Cancer

United States
Guerbet
Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)

Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (ODYSSEY)

Cognitive Function | Motor Function | Contrast Media

United States, Korea, Republic of, Italy, Brazil, Canada, Russian Federation
University of Southern California
National Cancer Institute (NCI)

Terminated

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Multiple Sclerosis | Metastatic Malignant Neoplasm in the Brain | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult... and other conditions

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

QSM and Regional DCE MRI Permeability Using GOCART Technique

Intracranial Neoplasm

United States
Cedars-Sinai Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Whole-Heart Myocardial Blood Flow Quantification Using MRI

Coronary Artery Disease | Coronary Microvascular Disease

United States
Northwestern University
National Cancer Institute (NCI)

Not yet recruiting

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Prostate Carcinoma

United States

Search clinical trials for: Multihance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations